BioXcel Therapeutics (BTAIQ) Net Equity Issued and Repurchased (2018 - 2026)
BioXcel Therapeutics (BTAIQ) reported Net Equity Issued and Repurchased of $3.11 million for Q2 2026, compared with $140,000 a year earlier and down 63.4% from the prior quarter.
Powered by 
Analysis
BioXcel Therapeutics (BTAIQ) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, BioXcel Therapeutics' Net Equity Issued and Repurchased came in at $55.6 million, up 157.3% year-over-year; for FY2025, it came in at $58.14 million, up 46.5% from FY2024.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of -25.6% (FY2020 to FY2025).
- By year, Net Equity Issued and Repurchased came in at $39.69 million in FY2024, $508,000 in FY2023 (+79.5%), $283,000 in FY2022 (-99.7%) and $100.99 million in FY2021 (-60.5%).
- Five-year quarterly Net Equity Issued and Repurchased spans a low of -$34,000 in Q3 2021 and a high of $38.23 million in Q3 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at $8.5 million (Q1 2026), $5.76 million (Q4 2025) and $38.23 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 43.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 9.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | BioXcel Therapeutics | 1.57 Mn | 1.57 Mn | 160,000.00 | 3.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.11 Mn |
| Mar 31, 2026 | 8.50 Mn |
| Dec 31, 2025 | 5.76 Mn |
| Sep 30, 2025 | 38.23 Mn |
| Jun 30, 2025 | 140,000.00 |
| Mar 31, 2025 | 14.01 Mn |
| Dec 31, 2024 | 7.00 Mn |
| Sep 30, 2024 | 467,000.00 |
| Jun 30, 2023 | 250,000.00 |
| Mar 31, 2023 | 258,000.00 |
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | 48,000.00 |
| Sep 30, 2021 | -34,000.00 |
| Jun 30, 2021 | 100.18 Mn |
| Mar 31, 2021 | 852,000.00 |
| Dec 31, 2020 | -34,000.00 |
| Sep 30, 2020 | 187.01 Mn |
| Mar 31, 2020 | 68.81 Mn |
| Dec 31, 2019 | 74,000.00 |
| Sep 30, 2019 | 17.51 Mn |
API Access
BioXcel Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BTAIQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();